BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY《临床血液学最佳实践与研究》(可网站投稿)

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY《临床血液学最佳实践与研究》(季刊). Best Practice & Research Clinical Haematology provides a comprehensive review of current clinical practice and thinking within the specialty of haematology. All chapters are commissioned and written by an international team of practicing clinicians with the Guest Editors for each issue drawn from a pool of renowned experts and opinion leaders.

杂志简称:best pract res cl ha
中文译名:《临床血液学最佳实践与研究》
收录属性:scie(2024版), 目次收录(维普),英文期刊,
自引率:2.00%
投稿方向:医学、hematology 血液学

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY《临床血液学最佳实践与研究》

SCI/E期刊基本信息

出版周期:季刊 地区:英国
中科院分区:3区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:非OA期刊
国际标准刊号:ISSN1521-6926;E-ISSN1532-1924
杂志语言:英语
出版国家:英国

杂志官网 联系方式

出版地址:ELSEVIER SCI LTD,THE BOULEVARD,LANGFORD LANE,KIDLINGTON,OXFORD,ENGLAND,OXON,OX5 1GB
杂志邮箱:
投稿网址:https://www.editorialmanager.com/ybeha
杂志官方网址:https://www.journals.elsevier.com/best-practice-and-research-clinical-haematology
出版商网址:http://www.elsevier.com

杂志投稿要求

投稿须知【杂志社官方网站信息】

Guide for Authors

Best Practice & Research Clinical Haematology publishes review articles integrating the results from the latest original research articles into practical, evidence-based review articles. These articles seek to address the key clinical issues of diagnosis, treatment and patient management. Each issue follows a problem-orientated approach which focuses on the key questions to be addressed, clearly defining what is known and not known, covering the spectrum of clinical and laboratory haematological practice and research. Although most reviews are invited, the Editor welcomes suggestions from potential authors.

Author queries can also be sent to the journal's Managing Editor: Berverly Burns beha@elsevier.com

Ethics in publishing

Please see our information on Ethics in publishing.

Identifying information, including patients' images, names, initials, or hospital numbers, should not be included in videos, recordings, written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and you have obtained written informed consent for publication in print and electronic form from the patient (or parent, guardian or next of kin where applicable). If such consent is made subject to any conditions, Elsevier must be made aware of all such conditions. Written consents must be provided to Elsevier on request. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. If such consent has not been obtained, personal details of patients included in any part of the paper and in any supplementary materials (including all illustrations and videos) must be removed before submission.

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/46589

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 杂志信息如有错漏 请在下方留言。

上一篇 2025年3月6日 下午1:29
下一篇 2025年3月6日 下午1:42

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

QQ:321628655
邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息